Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEISB.L Regulatory News (EISB)

  • There is currently no data for EISB

TR1 notification

17 Oct 2022 10:00

RNS Number : 9355C
East Imperial PLC
17 October 2022
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

East Imperial Plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Taylor Partners Limited

City and country of registered office (if applicable)

Auckland, New Zealand

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

16/09/2022

6. Date on which issuer notified (DD/MM/YYYY):

22/09/2022

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

15.08%

15.08%

Position of previous notification (if

applicable)

18.6%

18.6%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Ordinary Shares

51,000,000

15.08%

SUBTOTAL 8. A

51,000,000

15.08%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

N/A

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

 

SUBTOTAL 8.B.2

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

 

Place of completion

Auckland, New Zealand

Date of completion

22/09/2022

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLFIFSTIILSLIF
Date   Source Headline
24th Nov 20227:00 amRNSAppointment of US Bottling Partner
17th Oct 202210:00 amRNSTR1 notification
14th Sep 202211:06 amRNSSecond Price Monitoring Extn
14th Sep 202211:00 amRNSPrice Monitoring Extension
14th Sep 20227:00 amRNSInterim results
1st Sep 20227:10 amRNSAppointment of WH Ireland as Joint Broker
12th Aug 20229:05 amRNSSecond Price Monitoring Extn
12th Aug 20229:00 amRNSPrice Monitoring Extension
12th Aug 20227:00 amRNSChina Distribution Agreement
21st Jul 20227:00 amRNSPre-Close Trading Statement
1st Jun 20221:44 pmRNSResult of AGM
27th May 20222:00 pmRNSNotice of AGM: Correction
10th May 20227:00 amRNSPosting of Annual Report and Notice of AGM
5th May 20227:00 amRNSFull Year Results
29th Apr 202212:40 pmRNSShort Delay to Publication of Annual Report
8th Apr 20224:41 pmRNSSecond Price Monitoring Extn
8th Apr 20224:35 pmRNSPrice Monitoring Extension
3rd Mar 20222:05 pmRNSSecond Price Monitoring Extn
3rd Mar 20222:00 pmRNSPrice Monitoring Extension
25th Feb 20228:46 amRNSDirectorship Change
18th Feb 20229:47 amRNSDirector/PDMR Shareholding
19th Jan 20227:00 amRNSUS Distribution Agreement
13th Jan 20227:00 amRNSPlacing and year-end update
10th Dec 20215:00 pmRNSDirector/PDMR Shareholding
9th Dec 20219:00 amRNSDirector/PDMR Shareholding
3rd Dec 20212:23 pmRNSDirectorate Changes and Withdrawal of Requisition
17th Nov 20217:00 amRNSRequisition of Extraordinary General Meeting
5th Nov 20217:00 amRNSSingapore Distribution Partner
1st Nov 20217:00 amRNSAppointment of Head of Sales for North America
19th Oct 20217:00 amRNSAppointments to new Strategic Advisory Board
29th Sep 202112:56 pmRNSShareholder Update
13th Sep 20217:00 amRNSTrading Update
13th Sep 20217:00 amRNSBermele Interim Accounts
7th Sep 20214:41 pmRNSSecond Price Monitoring Extn
7th Sep 20214:36 pmRNSPrice Monitoring Extension
7th Sep 20212:05 pmRNSSecond Price Monitoring Extn
7th Sep 20212:00 pmRNSPrice Monitoring Extension
27th Aug 20214:40 pmRNSSecond Price Monitoring Extn
27th Aug 20214:35 pmRNSPrice Monitoring Extension
27th Aug 20219:05 amRNSSecond Price Monitoring Extn
27th Aug 20219:00 amRNSPrice Monitoring Extension
27th Aug 20217:37 amRNSNew Supply Agreements
16th Aug 20212:05 pmRNSSecond Price Monitoring Extn
16th Aug 20212:00 pmRNSPrice Monitoring Extension
6th Aug 20217:00 amRNSSupply Agreement
27th Jul 20214:40 pmRNSSecond Price Monitoring Extn
27th Jul 20214:35 pmRNSPrice Monitoring Extension
27th Jul 20212:06 pmRNSSecond Price Monitoring Extn
27th Jul 20212:00 pmRNSPrice Monitoring Extension
23rd Jul 20217:00 amRNSChange of Name

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.